MedTrace Logo

Early Biomarkers of Autism in Infants With Tuberous Sclerosis Complex (TSC)

NCT01780441 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 166

Last updated 2021-02-04

No results posted yet for this study

Summary

The investigators are enrolling 3-12 month old infants with a diagnosis of tuberous sclerosis complex (TSC) for a new study on early markers of autism. The study is looking for early signs for autism in a population (TSC) where autism is common. The goal of this project is to use behavioral testing, MRI and EEG techniques to identify children at risk for developing autism starting at 3 months of age and continuing until 36 months of age. Throughout the study, the investigators will recommend Early Intervention services for any child who shows early signs of autism.

Conditions

  • Tuberous Sclerosis Complex

Sponsors & Collaborators

  • National Institute of Neurological Disorders and Stroke (NINDS)

    collaborator NIH

  • Tuberous Sclerosis Alliance

    collaborator OTHER

  • Boston Children's Hospital

    lead OTHER

Principal Investigators

  • Mustafa Sahin, MD, PhD · Boston Children's Hospital

  • Darcy Krueger, MD, PhD · Children's Hospital Medical Center, Cincinnati

Eligibility

Min Age
3 Months
Max Age
12 Months
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2019-12-31
Completion
2020-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01780441 on ClinicalTrials.gov